UNSPSC 51313302: Thiazinam or thiazinamium

This classification denotes a histamine-1 receptor antagonist with the molecular formula C18H23N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 666W2P28N2, chemically known as 10h-phenothiazine-10-ethanaminium, n,n,n,alpha-tetramethyl-, methyl sulfate but generally known as thiazinamium, which bears US NIH Compound Identifier 6015. European Medicines Agency schedules Thiazinamium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15532MIG.

As of Q4 2014, THIAZINAMIUM remains the US FDA Preferred Term for this commodity. Thiazinamium bears US NLM identifiers UMLS ID C0039857 and NCI Concept Code C84203. SMILES: S1C2C(N(CC([N](C)(C)C)C)C3C1CCCC3)CCCC2.S(=O)(=O)(OC)O.

UNSPSC 51313302 Thiazinam or thiazinamium is a Commodity code that records pharmaceutical procurement activity in state and local government, though the recent opportunities block shows a mismatch between the code's nominal scope and what is actually being purchased. The single recent solicitation under this code — Seminole County, Florida's IFB 60459723LAS — seeks naloxone and drug deactivation systems for community health support, not thiazinamium compounds. Issuing bodies using this code span county governments and special-purpose districts focused on public health and emergency response. The procurement structure reflects standard state and local practice: electronic bid submission through the county's e-Procurement Portal, fixed-fee pricing with unit costs per line item, drug-free workplace and E-Verify compliance requirements, workers' compensation and commercial general liability insurance, and a probationary termination clause.

The code shows little relevant recent activity aligned to its pharmaceutical classification. Seminole County's naloxone and deactivation systems procurement, posted June 30, 2026 with a response deadline of July 26, 2023, represents the only indexed opportunity; the contradictory dates suggest a data quality issue in the source record. The contract calls for 1,900 units of naloxone and 800 drug deactivation systems delivered quarterly to the Seminole County Community Health Building in Sanford, Florida, with potential FEMA funding and federal compliance obligations including Clean Air Act and Federal Water Pollution Control Act adherence. The two-year initial term with one-year renewal option and fixed-fee structure indicate a recurring procurement vehicle for county health operations. The code appears underutilized or misclassified in state and local procurement systems; business development activity should verify whether thiazinamium itself is actually being solicited under this code in other jurisdictions before committing resources.